Which element is NOT typically included in the Validation Report?

The inclusion of a detailed financial analysis of the validation process is not standard practice in a Validation Report for cytometry or similar laboratory settings. Validation Reports primarily focus on demonstrating that the assay or technique produces reliable and consistent results according to specified criteria. This means that they generally include critical components such as reagent tables with lot numbers to ensure traceability of the materials used, statistical results to convey the significance and reliability of the data, and an appendix of individual results to provide comprehensive documentation of all findings.

These elements contribute directly to the validation's scientific integrity and reproducibility, which are paramount in laboratory practices. While financial considerations may be relevant to the overall project, they are not included in the technical validation aspects of the report. This distinction underlines the necessity for validation documentation to remain focused on the assay's technical reliability rather than the associated costs.